Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Talis Biomedical Corp (TLIS) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Talis Biomedical Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1584751.
Total stock buying since 2021: $106,747,920.
Total stock sales since 2021: $210,665.
Total stock option exercises since 2021: $78,532.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 45,133 | $103,020 | 0 | $0 | 0 | $0 |
| 2021 | 6,709,000 | $106,644,900 | 27,502 | $210,665 | 52,355 | $78,532 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-09 | 30,600 | $46,240 | 0 | $0 | 0 | $0 |
| 2024-08 | 14,533 | $56,780 | 0 | $0 | 0 | $0 |
| 2021-11 | 50,000 | $218,250 | 0 | $0 | 0 | $0 |
| 2021-08 | 0 | $0 | 27,502 | $210,665 | 52,355 | $78,532 |
| 2021-05 | 20,000 | $202,650 | 0 | $0 | 0 | $0 |
| 2021-02 | 6,639,000 | $106,224,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-06 | Leonard Braden Michael | Buy | 25,000 | 1.48 | 37,100 |
| 2024-09-05 | Leonard Braden Michael | Buy | 5,100 | 1.40 | 7,140 |
| 2024-09-03 | Leonard Braden Michael | Buy | 500 | 4.00 | 2,000 |
| 2024-08-30 | Leonard Braden Michael | Buy | 151 | 4.25 | 641 |
| 2024-08-28 | Leonard Braden Michael | Buy | 1,215 | 3.96 | 4,815 |
| 2024-08-26 | Leonard Braden Michael | Buy | 13,167 | 3.90 | 51,324 |
| 2021-11-18 | Baker Brothers Life Sciences Lp | Buy | 50,000 | 4.37 | 218,250 |
| 2021-08-13 | Ramakrishnan Ramesh (Other) | Sale | 27,502 | 7.66 | 210,665 |
| 2021-08-13 | Ramakrishnan Ramesh (Other) | Option Ex | 52,355 | 1.50 | 78,532 |
| 2021-05-17 | Scott Randal W. (Director) | Buy | 11,000 | 10.11 | 111,210 |
| 2021-05-14 | Scott Randal W. (Director) | Buy | 9,000 | 10.16 | 91,440 |
| 2021-02-17 | Ramakrishnan Ramesh (Sr. Vice President, R&D) | Buy | 1,000 | 16.00 | 16,000 |
| 2021-02-17 | Flick Karen E. (Chief of Staff, Sr. VP, Legal) | Buy | 2,000 | 16.00 | 32,000 |
| 2021-02-17 | Liu Douglas (Sr. Vice President, Operations) | Buy | 4,000 | 16.00 | 64,000 |
| 2021-02-17 | Posard Matthew L. (Director) | Buy | 62,500 | 16.00 | 1,000,000 |
| 2021-02-17 | Moody John Roger Jr (Chief Financial Officer) | Buy | 1,700 | 16.00 | 27,200 |
| 2021-02-17 | Scott Randal W. (Director) | Buy | 312,500 | 16.00 | 5,000,000 |
| 2021-02-17 | Popovits Kimberly J (Director) | Buy | 5,300 | 16.00 | 84,800 |
| 2021-02-17 | Baker Julian (Director) | Buy | 6,250,000 | 16.00 | 100,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of TLIS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Talis Biomedical Corp (symbol TLIS, CIK number 1584751) see the Securities and Exchange Commission (SEC) website.